BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 279713)

  • 1. Cell-mediated responses in dogs with spontaneous neoplasms. II. Detection by direct leukocyte migration inhibition technique.
    Gorman NT; Betton GR
    J Natl Cancer Inst; 1978 Oct; 61(4):1095-100. PubMed ID: 279713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated responses in dogs with spontaneous neoplasms. I. Detection of cell-mediated cytotoxicity by the chromium-51 release assay.
    Betton GR; Gorman NT
    J Natl Cancer Inst; 1978 Oct; 61(4):1085-93. PubMed ID: 279712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors.
    Char DH
    Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):176-9. PubMed ID: 832980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic superficial keratitis in dogs: detection of cellular hypersensitivity.
    Campbell LH; Okuda HK; Lipton DE; Reed C
    Am J Vet Res; 1975 May; 36(5):669-71. PubMed ID: 1169896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
    Cochran AJ; Spilg WG; Mackie RM; Thomas CE
    Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated and humoral immune responses of German Shepherd Dogs and Beagles to experimental infection with Ehrlichia canis.
    Nyindo M; Huxsoll DL; Ristic M; Kakoma I; Brown JL; Carson CA; Stephenson EH
    Am J Vet Res; 1980 Feb; 41(2):250-4. PubMed ID: 6989300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-directed immunity in human neuroblastoma.
    Morrison LJ; Cochran AJ; Baird GM; Campbell AM; Willoughby ML
    Am J Pediatr Hematol Oncol; 1982; 4(1):3-9. PubMed ID: 7046494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of in vitro and in vivo tests for cell-mediated immunity in the dog.
    Thilsted JP; Shifrine M; Wiger N
    Am J Vet Res; 1979 Sep; 40(9):1313-5. PubMed ID: 525939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
    Nifontova TP
    Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
    Emmrich F; Ambrosius H
    Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous mammary tumors in mongrel dogs. A relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cells.
    Sedlacek HH; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():399-412. PubMed ID: 608530
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
    Lee C; Chen S; Lin T
    Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
    Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
    Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancing antimelanoma immune responses through apoptosis.
    Bianco SR; Sun J; Fosmire SP; Hance K; Padilla ML; Ritt MG; Getzy DM; Duke RC; Withrow SJ; Lana S; Matthiesen DT; Dow SW; Bellgrau D; Cutter GR; Helfand SC; Modiano JF
    Cancer Gene Ther; 2003 Sep; 10(9):726-36. PubMed ID: 12944992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.